| Stem definition | Drug id | CAS RN |
|---|---|---|
| platelet aggregation inhibitors | 2423 | 125926-17-2 |
None
None
None
None
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Interstitial lung disease | 45.56 | 31.05 | 22 | 747 | 112578 | 79631041 |
| Hepatic function abnormal | 37.99 | 31.05 | 17 | 752 | 73090 | 79670529 |
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D005343 | Fibrinolytic Agents |
| MeSH PA | D006401 | Hematologic Agents |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D010975 | Platelet Aggregation Inhibitors |
| MeSH PA | D018490 | Serotonin Agents |
| MeSH PA | D012702 | Serotonin Antagonists |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.41 | acidic |
| pKa2 | 7.75 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | GPCR | ANTAGONIST | Ki | 8.50 | IUPHAR | ||||
| 5-hydroxytryptamine receptor 2B | GPCR | ANTAGONIST | Ki | 6.60 | IUPHAR | ||||
| 5-hydroxytryptamine receptor 2C | GPCR | ANTAGONIST | Ki | 7.40 | IUPHAR | ||||
| Serotonin 2 (5-HT2) receptor | GPCR | Ki | 7.75 | CHEMBL |
| ID | Source |
|---|---|
| D01624 | KEGG_DRUG |
| C0286592 | UMLSCUI |
| CHEBI:135697 | CHEBI |
| CHEMBL541829 | ChEMBL_ID |
| CHEMBL52939 | ChEMBL_ID |
| DB12163 | DRUGBANK_ID |
| C064294 | MESH_SUPPLEMENTAL_RECORD_UI |
| 5160 | PUBCHEM_CID |
| 210 | IUPHAR_LIGAND_ID |
| 6611 | INN_ID |
| 135159-51-2 | SECONDARY_CAS_RN |
| 19P708E787 | UNII |
None